About Syqe
Syqe is a Healthcare company based in Tel Aviv (Israel) founded in 2011 by Perry Davidson and Benny Shwartz, and was acquired by Vectura in July 2023. Precise dosing inhaler for medical cannabis is developed. Syqe has raised $75.67 million across 4 funding rounds from investors including OurCrowd, Philip Morris International and Phillips Medisize. Its chief executive, as recorded, is Hagit Kamin. Syqe offers products and services including SyqeAir Inhaler, SyqeAir Cartridge, and Case for SyqeAir Inhaler. Its focus areas include HealthTech, Cannabis HealthTech, Cannabinoid Drug Delivery Devices and Inhaled. Its competitors include Kanabo and Cannabis Technology House; 2 of its 2 listed competitors have raised funding.
Company details
Syqe was established in 2011 in Tel Aviv, Israel, within the medical cannabis sector. An inhalation device called Air is produced to deliver controlled THC doses. Pain reduction is facilitated, psychoactive effects are managed, and daily functioning is supported through this system. Operations center on device development and precise medication administration for therapeutic use.
Products & Services of Syqe
Syqe offers a comprehensive portfolio of products and services, including SyqeAir Inhaler, SyqeAir Cartridge, and Case for SyqeAir Inhaler.
Device for precise metered-dose cannabis administration
Cartridges providing cannabis doses for the inhaler
Protective case to store and carry the inhaler
Apps and channels of Syqe
its YouTube channel SyqeAir - סאיקי אייר has 529 subscribers and 30 videos.
Videos from Syqe
The most watched videos on Syqe's YouTube channel, SyqeAir - סאיקי אייר (529 subscribers). Click a video to play it here.
More on SyqeAir - סאיקי אייר.
Funding Insights of Syqe
Syqe has successfully raised a total of $75.67M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $50 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $75.67M
- Total Rounds 4
- Last Round Series A — $50M
- First Round $2.23M
(Apr 2015)
- Investors Count 4
All 4 funding rounds of Syqe with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | $50M | Series A | – | Shavit Capital | |
| Nov 2018 | $3.43M | Series A | – | – | – |
| Jan 2016 | $20M | Series A | – | Philip Morris International | – |
| Apr 2015 | $2.23M | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in Syqe
Syqe has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include OurCrowd, Philip Morris International and Phillips Medisize.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in Israel are managed by Shavit Capital. | shavitcapital.com | Jerusalem, Israel | ||
Multi-category tobacco products, including cigarettes and heated options, are manufactured. | 1847 | pmi.com | Neuchatel, Switzerland | |
Martin Bauer is engaged in producing plant-based products for various industries. | 1930 | martin-bauer-group.com | ||
Network connecting investors to startups, venture capital funds, and alternatives | 2013 | ourcrowd.com | Jerusalem, Israel | |
Inhaled therapeutics for respiratory diseases are developed. | 1997 | vectura.com | Chippenham, United Kingdom |
Investor details for Syqe
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Syqe
3 people are tracked at Syqe (3 in leadership).
| Name | Role | Group |
|---|---|---|
Perry Davidson | Co-Founder | Leadership |
Benny Shwartz | Co-Founder | Leadership |
Hagit Kamin | CEO | Leadership |
Complete people profiles for Syqe
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Syqe
4 dated milestones of Syqe across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Syqe is founded.
- Funding First funding round of $2.2M.
- Funding Latest funding round, Series A, of $50.0M.
- Exit Acquired by Vectura.
Competitors of Syqe
Syqe has 2 listed competitors in our database, 2 of them funded. They include Kanabo and Cannabis Technology House.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kanabogroup.com | 2016 | Tel Aviv, Israel | $1.08M | Cannabis-based medical and consumer products are developed by Kanabo. | ||
| cannabistechnologyhouse.com | 2019 | Ness Ziona, Israel | $1M | Smart devices for cannabis delivery systems are provided. |
Detailed competitors of Syqe
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Syqe
The website of Syqe (syqe.com) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 21.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Syqe
Complete news archive for Syqe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syqe
Syqe was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Syqe is headquartered in Tel Aviv, Israel.
Hagit Kamin is the CEO of Syqe, as recorded in our data.
Syqe is a funded company, having raised a total of $75.67M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.23M, raised on Apr 2015.
Syqe was established in 2011 in Tel Aviv, Israel, within the medical cannabis sector. An inhalation device called Air is produced to deliver controlled THC doses. Pain reduction is facilitated, psychoactive effects are managed, and daily functioning is supported through this system. Operations center on device development and precise medication administration for therapeutic use.
Syqe's top competitors include Kanabo and Cannabis Technology House.
Syqe offers SyqeAir Inhaler, SyqeAir Cartridge, and Case for SyqeAir Inhaler.
Syqe has 5 investors. Key investors include OurCrowd, Philip Morris International, Phillips Medisize, Shavit Capital, and Martin Bauer.
Syqe operates through Syqe.
Yes. Syqe was acquired by Vectura in July 2023.